Conference Proceedings
EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
C Correll, R Goldman, M Tocco, A Pikalov, L Deng, A Loebel, D Coghill
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | SAGE PUBLICATIONS LTD | Published : 2019
Grants
Funding Acknowledgements
Funded by Sunovion Pharmaceuticals Inc., Sumitomo Dainippon Pharma and Servier Australia